NEWS IN BRIEF

Vince & Associates awarded $9.5m contract for clinical pharmacology studies

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/BrianAJackson)
(Image: iStock/BrianAJackson)

Related tags: Pharmacology

Vince & Associates will conduct clinical pharmacology studies to support the development of new medications to treat substance use disorders.

The five-year contract, which began September 2017 and is worth up to $9.5m, was awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.

Vince & Associates Clinical Research, an Altasciences company​, is an early phase contract research organization (CRO) headquartered in Overland Park, KS.

According to the company, it will conduct clinical pharmacology studies to support the development of new medications for the treatment of substance use disorders.

The company was previously awarded approximately $4m by the NIDA as part of a multi-year contract that ran from 2012 to 2017.

In October​, Amygdala Neurosciences Inc. contracted Vince & Associates to conduct a Phase Ib alcohol interaction study of ANS-667 also for the treatment of substance abuse.

Related topics: Clinical Development, Phase I-II

Related news

Show more

Related products

show more

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Parents as Gatekeepers for Children with Cancer

Parents as Gatekeepers for Children with Cancer

PRA Health Sciences | 08-Jun-2020 | Technical / White Paper

The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...

Related suppliers

Follow us

Products

View more

Webinars